CA
BIIB icon

Clearstead Advisors’s Biogen BIIB Stock Holding History

Clearstead Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Buy
2,523
+274
+12% +$50.5K ﹤0.01% 731
2025
Q4 		$396K Buy
2,249
+747
+50% +$122K 0.01% 726
2025
Q3 		$210K Sell
1,502
-181
-11% -$24.5K ﹤0.01% 871
2025
Q2 		$211K Buy
1,683
+490
+41% +$61.1K ﹤0.01% 880
2025
Q1 		$163K Buy
1,193
+75
+7% +$10.7K ﹤0.01% 881
2024
Q4 		$171K Sell
1,118
-302
-21% -$50.9K ﹤0.01% 902
2024
Q3 		$275K Sell
1,420
-37
-3% -$7.74K ﹤0.01% 751
2024
Q2 		$338K Buy
1,457
+16
+1% +$3.48K 0.01% 635
2024
Q1 		$325K Sell
1,441
-387
-21% -$90.6K 0.02% 388
2023
Q4 		$473K Sell
1,828
-1,525
-45% -$375K 0.03% 317
2023
Q3 		$862K Buy
3,353
+1,905
+132% +$510K 0.03% 324
2023
Q2 		$412K Sell
1,448
-3
-0.2% -$893 0.03% 316
2023
Q1 		$403K Sell
1,451
-2
-0.1% -$553 0.03% 291
2022
Q4 		$402K Hold
1,453
– – 0.03% 283
2022
Q3 		$388K Hold
1,453
– – 0.04% 269
2022
Q2 		$296K Hold
1,453
– – 0.02% 322
2022
Q1 		$306K Buy
1,453
+226
+18% +$49.1K 0.02% 345
2021
Q4 		$294K Buy
1,227
+213
+21% +$54.8K 0.02% 330
2021
Q3 		$287K Hold
1,014
– – 0.02% 320
2021
Q2 		$351K Buy
1,014
+492
+94% +$149K 0.03% 267
2021
Q1 		$146K Buy
522
+138
+36% +$37.2K 0.01% 370
2020
Q4 		$94K Hold
384
– – 0.01% 424
2020
Q3 		$109K Buy
384
+114
+42% +$31.8K 0.01% 360
2020
Q2 		$72K Hold
270
– – 0.01% 391
2020
Q1 		$85K Buy
+270
New +$81.9K 0.01% 346

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clearstead Advisors's BIIB Position: Q1 2026 in Review

Clearstead Advisors increased its Biogen (BIIB) stake by 12% in Q1 2026, buying an estimated $50.5K and bringing the position to 2,523 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Clearstead Advisors first reported a position in BIIB in Q1 2020 and has held it in 25 quarters since. The position peaked at $862K in Q3 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Clearstead Advisors held 2,523 shares of Biogen worth $463K as of Q1 2026.
  • Clearstead Advisors bought 274 Biogen shares in Q1 2026, an estimated $50.5K.
  • Biogen made up ﹤0.01% of Clearstead Advisors's portfolio in Q1 2026, its #731 holding.
  • Clearstead Advisors first reported a position in Biogen in Q1 2020 and has held it in 25 quarters since.
  • Clearstead Advisors's Biogen position peaked at $862K in Q3 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.